Health Condition 1: C269- Malignant neoplasm of ill-definedsites within the digestive system
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: Nil: Nil
Sponsors
Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients with intra-abdominal first recurrence of retroperitoneal liposarcoma. Including both patients who underwent surgery and those who did not undergo surgery.
Exclusion criteria
Exclusion criteria: 1. Incomplete initial primary resection (R2) 2. non-oncological/piecemeal resection of their primary retroperitoneal liposarcoma. 3. Distant metastatic disease 4. Patients with synchronous intra-abdominal malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify novel risk factors to predict recurrence risk following curative intent treatment of first local recurrence of retroperitoneal liposarcomaTimepoint: 6 months after completion of the data entry | — |
Secondary
| Measure | Time frame |
|---|---|
| To describe the pattern of 2nd recurrence of retroperitoneal liposarcomasTimepoint: 6 months after completion of the data entry;To identify predictors of early local relapse after surgical resection of first local recurrenceTimepoint: 6 months after completion of the data entry;To identify reasons for unresectability in patients with first intra-abdominal recurrence of RPLPSTimepoint: 6 months after completion of the data entry | — |
Countries
Australia, India
Contacts
Public ContactDr Shraddha Patkar
Tata Memorial Hospital, Mumbai
Outcome results
None listed